Digestive issues Difficulty in moving to maintenance or transitioning off the medications Not knowing what to eat to maximize the benefits of the medications Other challenges include slower metabolism, difficulty keeping weight off, and side effects that might make sticking with the medication harder
[DOI] [PubMed] [Google Scholar] 189
That approval does not make tesamorelin a general weight-loss or anti-aging drug for the broader population
Hiromichi Wakui has received research supports from AstraZeneca, Otsuka Pharmaceutical, and Kaneka Corporation, and honoraria from AstraZeneca, Otsuka Pharmaceutical, Kaneka Corporation, Kyowa Kirin, Sanwa Kagaku, Chugai Pharma, Kowa, Otsuka Pharmaceutical, Novartes, Mitsubishi-Tanabe Pharma, Bayer, and Daiichi-Sankyo Pharma